Evidence map›Paper›PMID 38537700›Full record

ArticleThe Journal of biological chemistry2024

Mimicking kidney flow shear efficiently induces aggregation of LECT2, a protein involved in renal amyloidosis.

Jeung-Hoi Ha, Yikang Xu, Harsimranjit Sekhon, Wenhan Zhao, Stephan Wilkens, Dacheng Ren, Stewart N Loh

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Pathogenesis and kidney prognosis of renal amyloidosis.Cellular and molecular life sciences : CMLS · 2026
    Review
  2. Article
  3. The role of shear forces in primary and secondary nucleation of amyloid fibrils.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jeung-Hoi HaDepartment of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, New York, USA.
Yikang XuDepartment of Biomedical and Chemical Engineering, Syracuse University, Syracuse, New York, USA.
Harsimranjit SekhonDepartment of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, New York, USA.
Wenhan ZhaoDepartment of Biomedical and Chemical Engineering, Syracuse University, Syracuse, New York, USA.
Stephan WilkensDepartment of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, New York, USA.
Dacheng RenDepartment of Biomedical and Chemical Engineering, Syracuse University, Syracuse, New York, USA; Department of Civil and Environmental Engineering, Syracuse University, Syracuse, New York, USA; Department of Biology, Syracuse University, Syracuse, New York, USA. Electronic address: dren@syr.edu.
Stewart N LohDepartment of Biochemistry and Molecular Biology, State University of New York Upstate Medical University, Syracuse, New York, USA. Electronic address: lohs@upstate.edu.
SUNY Upstate Medical University · USSyracuse University · US

Funding

Structure and Regulatory Mechanisms of the Vacuolar ATPaseR35GM141908 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI WILKENS, STEPHAN · 2021 to 2025
$2.1M
Controlling Catheter-Associated Urinary Tract Infections Using Smart Catheters with Rationally Designed Active TopographiesR01EB030621 · NIBIB · SYRACUSE UNIVERSITY · PI REN, DACHENG · 2021 to 2024
$1.5M
Molecular Devices for the Detection and Treatment of HCMV InfectionF30GM146428 · NIGMS · UPSTATE MEDICAL UNIVERSITY · PI Harsimranjit S Sekhon · 2022 to 2026
$268k
Mechanism and detection of LECT2 amyloidosisR56DK124335 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI LOH, STEWART N · 2021 to 2021
$100k
NIBIB NIH HHS R01 EB030621NIDDK NIH HHS R56 DK124335NIGMS NIH HHS F30 GM146428NIGMS NIH HHS R35 GM141908
6 · The paper itself

Abstract

Aggregation of leukocyte cell-derived chemotaxin 2 (LECT2) causes ALECT2, a systemic amyloidosis that affects the kidney and liver. Previous studies established that LECT2 fibrillogenesis is accelerated by the loss of its bound zinc ion and stirring/shaking. These forms of agitation create heterogeneous shear conditions, including air-liquid interfaces that denature proteins, that are not present in the body. Here, we determined the extent to which a more physiological form of mechanical stress-shear generated by fluid flow through a network of narrow channels-drives LECT2 fibrillogenesis. To mimic blood flow through the kidney, where LECT2 and other proteins form amyloid deposits, we developed a microfluidic device consisting of progressively branched channels narrowing from 5 mm to 20 μm in width. Shear was particularly pronounced at the branch points and in the smallest capillaries. Aggregation was induced within 24 h by shear levels that were in the physiological range and well below those required to unfold globular proteins such as LECT2. EM images suggested the resulting fibril ultrastructures were different when generated by laminar flow shear versus shaking/stirring. Importantly, results from the microfluidic device showed the first evidence that the I40V mutation accelerated fibril formation and increased both the size and the density of the aggregates. These findings suggest that kidney-like flow shear, in combination with zinc loss, acts in combination with the I40V mutation to trigger LECT2 amyloidogenesis. These microfluidic devices may be of general use for uncovering mechanisms by which blood flow induces misfolding and amyloidosis of circulating proteins.

Indexed as

Amyloid NeuropathiesIntercellular Signaling Peptides and ProteinsKidneyRenal Plasma FlowAmyloidHumansProtein AggregatesShear StrengthStress, MechanicalAmyloidIntercellular Signaling Peptides and ProteinsLECT2 protein, humanProtein AggregatesALECT2heparan sulfateheparinhydrodynamic shearmicrofluidic deviceprotein misfoldingsystemic amyloidosis

Identifiers

PMID38537700
PMCPMC11040205
OpenAlexW4393187835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.